Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Ondine Biomedical, Inc.
Telephone
1.604.669.0555
Address
Suite 888, 1100 Melville Street, Vancouver, BC V6E 4A6
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.08 - 0.19
Trade Value (12mth)
US$12,462.00
1 week
0%
1 month
30.43%
YTD
71.43%
1 year
76.47%
All time high
0.60
EPS 3 yr Growth
-73.00%
EBITDA Margin
-921.40%
Operating Cashflow
-$16m
Free Cash Flow Return
-343.70%
ROIC
-423.40%
Interest Coverage
-401.70
Quick Ratio
1.80
Shares Outstanding (Fully Diluted)
437m
HALO Sector
Healthcare
Next Company Report Date
03-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
CAD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 06 May 26 | |
| 06 May 26 | |
| 06 May 26 | |
| 30 April 26 | |
| 29 April 26 |
Historical data
Forecast data
| CAD | 2020 | 2021 | 2022 | 2023 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.1 | -0.07 | -0.07 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.1 | -0.07 | -0.07 | | | | ||
Growth | % | | | | | 61.3 | 26.5 | 5 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
